• ResMed average return on tangible equity for 2023 was 118.55, a 33.44% decline from 2022.
• ResMed average return on tangible equity for 2022 was 88.84, a 12.86% increase from 2021.
• ResMed average return on tangible equity for 2021 was 101.95, a 598.29% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.